HEMOBLAST™ Bellows

DEVICE4 trials

Sponsors

Biom'Up France SAS, Dilon Technologies Inc.

Conditions

HemostasisSurgical Bleeding

Unknown Phase

Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery

CompletedNCT03873181

Biom'Up France SASHemostasis

Start: 2019-05-16End: 2020-08-26Updated: 2020-12-04

Post-Market Evaluation of HEMOBLAST™ Bellows in Open Gynecological, Urological, ENT, Head, Neck, and Vascular Surgeries

TerminatedNCT03873168

Biom'Up France SASHemostasis

Start: 2019-05-09End: 2021-07-27Updated: 2021-08-30

Post-market Evaluation of HEMOBLAST™ Bellows in Spine Surgery

WithdrawnNCT04471350

Biom'Up France SASHemostasis

Start: 2021-06-30End: 2022-08-31Updated: 2021-08-30

Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery

CompletedNCT04734535

Dilon Technologies Inc.Surgical Bleeding

Start: 2021-03-08End: 2024-02-05Updated: 2024-04-02